USA Financial Formulas’s Dorman Products DORM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-387
Closed -$46.6K 273
2025
Q1
$46.6K Buy
387
+217
+128% +$27.7K 0.01% 207
2024
Q4
$22K Sell
170
-342
-67% -$43.8K ﹤0.01% 265
2024
Q3
$57.9K Buy
+512
New +$53.8K 0.01% 214
2018
Q1
Sell
-6,578
Closed -$402K 339
2017
Q4
$402K Sell
6,578
-2,062
-24% -$140K 0.1% 192
2017
Q3
$619K Sell
8,640
-5,826
-40% -$419K 0.15% 130
2017
Q2
$1.2M Sell
14,466
-4,376
-23% -$357K 0.29% 80
2017
Q1
$1.55M Buy
18,842
+12,002
+175% +$891K 0.37% 66
2016
Q4
$500K Buy
6,840
+1,486
+28% +$101K 0.12% 141
2016
Q3
$342K Sell
5,354
-33,828
-86% -$2.08M 0.09% 181
2016
Q2
$2.24M Buy
+39,182
New +$2.11M 0.61% 59

Other funds holding DORM

USA Financial Formulas's DORM Position: Q2 2025 in Review

USA Financial Formulas sold out of Dorman Products (DORM) in Q2 2025, closing a stake of 387 shares — an estimated $46.6K sold.

USA Financial Formulas first reported a position in DORM in Q2 2016 and held it in 10 quarters. The position peaked at $2.24M in Q2 2016. 340 funds tracked by Wall St. Rank hold DORM as of Q2 2025.

  • USA Financial Formulas reported no remaining Dorman Products position as of Q2 2025 after selling out during the quarter.
  • USA Financial Formulas sold 387 Dorman Products shares in Q2 2025, an estimated $46.6K.
  • USA Financial Formulas first reported a position in Dorman Products in Q2 2016 and held it in 10 quarters.
  • USA Financial Formulas's Dorman Products position peaked at $2.24M in Q2 2016.
  • 340 funds tracked by Wall St. Rank held Dorman Products as of Q2 2025.

Based on USA Financial Formulas's 13F filing for Q2 2025, filed 18 Jul 2025.